Roberts, A. W., Ma, S., Kipps, T. J., Coutre, S. E., Davids, M. S., Eichhorst, B., . . . Seymour, J. F. (2019). Efficacy of venetoclax in relapsed chronic lymphocytic leukemia is influenced by disease and response variables. Blood, 134(2), 111-122. https://doi.org/10.1182/blood.2018882555
Chicago Style (17th ed.) CitationRoberts, Andrew W., et al. "Efficacy of Venetoclax in Relapsed Chronic Lymphocytic Leukemia Is Influenced by Disease and Response Variables." Blood 134, no. 2 (2019): 111-122. https://doi.org/10.1182/blood.2018882555.
MLA (9th ed.) CitationRoberts, Andrew W., et al. "Efficacy of Venetoclax in Relapsed Chronic Lymphocytic Leukemia Is Influenced by Disease and Response Variables." Blood, vol. 134, no. 2, 2019, pp. 111-122, https://doi.org/10.1182/blood.2018882555.